TrialJournal of the American Heart Association2021

Activation of Glucagon-Like Peptide-1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism-Independent Pathway.

Qiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.